GlassScriptPhysician profile
Robert Anthony Conner
NPI 1053302745
$1,075.35
in general payments reported to CMS, 2019-2025
13 companies · $30.86 in 2025
The $30.86 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $133 · 2022: $563 · 2023: $334 · 2024: $13.25 · 2025: $30.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $378.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $599.24 | 2021-2023 | Xtandi, Veozah, Myrbetriq |
| Boston Scientific Corporation | $121.98 | 2022-2023 | Rezum Generator, Ams 700, Ams Ambicor |
| Abbvie INC. | $106.25 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $63.88 | 2023 | Prolaris |
| Endo Pharmaceuticals INC. | $33.50 | 2022-2023 | Xiaflex |
| Kerecis Limited | $22.40 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Myovant Sciences INC. | $19.52 | 2022 | |
| Coloplast Corp | $19.40 | 2022 | |
| 180 Medical, INC. | $18.98 | 2023 | Cure Catheter |
| Hollister Incorporated | $18.71 | 2023 | Infyna Chic |
| Urovant Sciences INC | $17.73 | 2022 | |
| Sumitomo Pharma America, INC. | $17.55 | 2023 | Gemtesa |
| Progenics Pharmaceuticals, INC. | $16.21 | 2023 | Pylarify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.